OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/23/2026
Back to search
Official data from USPTO
AENOVATION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AENOVATION
ST13
US500000079416055Class
39, 40, 42
Filing
79416055
Registration
8016918
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
07/23/2026
Trademark type
Word
Nice classes
39, 40, 42
Filing date
12/19/2024
Registration date
11/11/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/11/2025
Last transaction
07/23/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
DE
Examiner
CORNWELL, ANDREA B
Law office
M60
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Aenova Holding GmbH
Representatives
John Alumit ALUMIT IP
Technical classification
Nice Classes
Class 39Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 39
Packaging of goodspharmaceuticals
Class 40
Custom manufacture of pharmaceuticals
Class 42
Product development for others; product development consultation; product development; pharmaceutical research services; inspection of pharmaceuticals; pharmaceutical drug development services; pharmaceutical research and development; pharmaceutical products development; pharmaceutical product evaluation; laboratory research services relating to pharmaceuticals; development of pharmaceutical preparations and medicines; services for assessing the efficiency of pharmaceuticalstesting of pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development for the pharmaceutical industry; consultancy in the field of pharmaceutical research; consultancy services relating to product engineering; consultancy pertaining to pharmacology
Publications
History of USPTO decisions and trademark events.
26 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/06/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/05/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/18/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/30/2026
FIMP
FINAL DISPOSITION PROCESSED
05/30/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/19/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/11/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/11/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
11/11/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/23/2025
PUBO
PUBLISHED FOR OPPOSITION
09/23/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/17/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/27/2025
RFNT
REFUSAL PROCESSED BY IB
08/23/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/18/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/18/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/18/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/01/2025
RFRR
REFUSAL PROCESSED BY MPU
08/01/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/11/2025
CNRT
NON-FINAL ACTION WRITTEN
06/10/2025
DOCK
ASSIGNED TO EXAMINER
06/05/2025
MAFR
APPLICATION FILING RECEIPT MAILED
02/07/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/07/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/06/2025
Continuous trademark protection
Get notified about every new filing that threatens AENOVATION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.